Ocugen, Inc.
Ocugen, Inc. (OCGN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · OCGN · as of Mar 31, 2025
Ownership Breakdown
115
Institutional Holders
▼ 4 vs Q4
$54.18M
Total Inst. Value
▼ $3.52M vs Q4
338.52M
Shares Outstanding
freeFloat 93.60%
76.71M
13F Shares Held
▲ 5.04M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
OCGN largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. biological products, (no diagnostic substances) | 19.57M | 6.70% | 6.70% | $13.82B | May 2, 2025 | ▼ 376.1K |
VANGUARD GROUP INC biological products, (no diagnostic substances) | 16.68M | 5.71% | 5.71% | $11.78B | May 9, 2025 | ▲ 64.0K |
GEODE CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 6.89M | 2.36% | 2.36% | $4.87B | May 13, 2025 | ▲ 300.4K |
STATE STREET CORP biological products, (no diagnostic substances) | 5.93M | 2.03% | 2.03% | $4.19B | May 15, 2025 | ▲ 65.9K |
UBS GROUP AG biological products, (no diagnostic substances) | 4.37M | 1.50% | 1.50% | $3.08B | May 13, 2025 | ▲ 3.39M |
GMT CAPITAL CORP biological products, (no diagnostic substances) | 4.15M | 1.42% | 1.42% | $2.93B | May 15, 2025 | ▲ 1.70M |
RENAISSANCE TECHNOLOGIES LLC biological products, (no diagnostic substances) | 3.46M | 1.18% | 1.18% | $2.44B | May 14, 2025 | ▲ 1.37M |
NORTHERN TRUST CORP biological products, (no diagnostic substances) | 2.35M | 80.46% | 80.46% | $1.66B | May 13, 2025 | ▼ 57.7K |
GSA CAPITAL PARTNERS LLP biological products, (no diagnostic substances) | 1.64M | 56.10% | 56.10% | $1.16B | May 8, 2025 | ▲ 492.3K |
RINKEY INVESTMENTS biological products, (no diagnostic substances) | 1.16M | 39.88% | 39.88% | $822.49M | May 15, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
21
Increased
+8.18M shares3
New Positions
first time holders21
Decreased
−2.55M shares0
Sold Out
fully exitedNet shares change (top 50)
+5.63M
+8.18M / −2.55M
Net new holders
+3
3 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
OCGN insider trading · insider activity
Source: SEC Form 4
3
Buy transactions
3
Sell transactions
1.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Musunuri Shankar Chief Executive Officer | Jan 2, 2026 | Award | 3,123,201 | — | — | 4.96M | Form 4 ↗ |
Musunuri Shankar Chief Executive Officer | Jan 2, 2026 | Award | 3,123,201 | $1.38 | $4.31M | 3.12M | Form 4 ↗ |
Ramachandran Ramesh Chief Accounting Officer | Jan 2, 2026 | Award | 310,950 | $1.38 | $429.1K | 310.9K | Form 4 ↗ |
Ramachandran Ramesh Chief Accounting Officer | Jan 2, 2026 | Award | 207,300 | — | — | 209.1K | Form 4 ↗ |
Chandrasekhar Satishchandran director | Jun 5, 2025 | Award | 151,316 | $0.95 | $143.8K | 151.3K | Form 4 ↗ |
Coleman Blaise director | Jun 5, 2025 | Award | 151,316 | $0.95 | $143.8K | 151.3K | Form 4 ↗ |
Castillo Kirsten director | Jun 5, 2025 | Award | 151,316 | $0.95 | $143.8K | 151.3K | Form 4 ↗ |
Kompella Uday director | Jun 5, 2025 | Award | 151,316 | $0.95 | $143.8K | 151.3K | Form 4 ↗ |
Zhang Junge director | Jun 5, 2025 | Award | 151,316 | $0.95 | $143.8K | 151.3K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Ocugen, Inc. (OCGN) is primarily owned by institutional investors, who hold approximately 22.7% of total shares outstanding. Company insiders own approximately 6.40%, while retail and public investors account for the remaining 70.94%.
The largest institutional shareholder of Ocugen, Inc. is BLACKROCK, INC., holding approximately 19.57 million shares — equal to 6.70% of outstanding shares — as of March 31, 2025.
A total of 115 institutional investors currently hold OCGN stock, with a combined institutional value of approximately $54,175,291 as of the most recent 13F filing period.
Frequently asked questions
OCGN ownershipOcugen, Inc. (OCGN) is primarily owned by institutional investors, who hold approximately 22.7% of shares. The largest shareholder is BLACKROCK, INC. with a 6.70% stake. Company insiders hold 6.40%. Data sourced from SEC Form 13F as of March 31, 2025.